Welcome to GuruFocus Investment Space.

Please Join Us to share your investment ideas with more than 100,000 GuruFocus users.

Join      Log in

Dr. Paul Price Feed

Dr. Paul Price's Space » Latest Feeds

2016-06-28

2016-06-23

  • Dr. Paul Price commented on Chuck Carnevale's article 06-23 15:38
    Answers to the Hardest Question: When Do I Sell a Stock?
    The most common complaint I have heard from investors over my 40-plus years in the financial services industry is as follows: "Everyone wants to tell...
    View all 1 comment
    Dr. Paul Price 06-23 16:38
    • I agree that 'low price' is never a good reason to sell if fundamentals continue to look good. That typically happens during nasty bear markets which take most stocks down dramatically, even without any news to justify the drops. 

      If taxes are not a consideration I will usuaully sell when a stock is moderately above fair value with the idea of buying back if it dips again to a good discount. Holding onto what you know are overpriced shares often leads to long periods of flat, or down performance. 

      Stryker, one of your examples, could have been sold in late 2006, and repurchased, slightly cheaper, in 2013, saving a lot of agita and putting your money to much better use.
  • Dr. Paul Price commented on Dr. Paul Price's article 06-23 07:11
    Let Your 'Fear of Heights' Protect You
    Fear of heights is often considered a psychological abnormality. In the investment world, however, it can be a downright lifesaver. Stock...
    View all 3 comments
    Dr. Paul Price 06-23 08:11
    • I have a paid subscription to Morningstar's online service. That gives full reports including up to date analyst opinions, real-time prices and any between publishing date (hard-copy)  changes that might occur.

       

       

2016-06-22

2016-06-21

2016-06-20

2016-06-19

  • Dr. Paul Price commented on Dr. Paul Price's article 06-19 13:58
    Don’t Buy a 'Valuation High'
    Imagine you just had the best week ever. You got that promotion you’d been hoping for, along with a big raise. Your significant other said...
    View all 5 comments
    Dr. Paul Price 06-19 14:58
    • Biotechs rode a wave of rapid, and large, drug price increases to juice EPS over the past five years. There is now political pressure to voluntarily restrain that trend. 

      Profit growth rates will be lower than historical and thus P/Es are likely to stay below where they were in most recent years. Many drug company shares' multiple now appear to already reflect, or even over-discount that change. 

      I like and own GILD, of the ones you mentioned, right now.
  • Dr. Paul Price commented on Dr. Paul Price's article 06-19 09:25
    Don’t Buy a 'Valuation High'
    Imagine you just had the best week ever. You got that promotion you’d been hoping for, along with a big raise. Your significant other said...
    View all 3 comments
    Dr. Paul Price 06-19 10:25
    • Pgorobets,

      There have been millions of dollars of insider sells in HSIC during 2016 YTD against zero buys. 

      When company officers and directors are selling it seems self-serving to be actively buying back stock with shareholders' money, or debt.

       
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK